Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03122548
Title Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aduro Biotech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Medical Center Los Angeles California 90095 United States Details
University of Colorado Aurora Colorado 80045 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Johns Hopkins University Baltimore Maryland 21287 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
Virginia Mason Medical Center Seattle Washington 98101 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field